Site icon OncologyTube

Novel Therapeutics for Breast Cancer: HER2+ and Triple Negative Disease; New Pathways, Targets

In this presentation from the 14th Annual Best of San Antonio – Breast Cancer: Bench to Bedside, Dr. Debu Tripathy discusses novel therapeutics for the treatment of breast cancer, with a focus on HER2+ and triple negative disease.

Earn CME Credit for a related activity: http://elc.imedex.com/ELC/Specialty-Search.aspx?search=7244

© 2017 Imedex, LLC.

Advertisement
Exit mobile version